University of California, Irvine Medical Center-Department of Urology
Orange, California, 92868, United States
NCT Number: NCT00360477
The patient will be asked to participate in a research project designed to determine the best way to prevent bleeding and promote patient comfort after having kidney stones removed. Two standard methods for ending the surgery are being compared to a newer method. In one standard method, the patient will have a tube draining urine from the kidney after the procedure. This tube may also prevent bleeding from the kidney. In another standard method the patient will have a tube left internally that drains urine from the kidney to the bladder and a stitch will be used to close the incision and deeper tissues in the back. In the third potential option, a tube would be left internally to drain urine from the kidney to the patient's bladder and the surgical site would be filled with a clot promoting agent (FloSeal) which is a FDA approved agent specifically formulated to stop bleeding during surgical procedures.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Orange, California, 92868, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bioglue that seals the kidney
Nephrostomy tube for fluid drainage from the kidney
Stitch that closes the kidney
Time frame: one month
University of California, Irvine
Other
Prospective Randomized Trial of Floseal Tubeless Exit vs. Cope Loop Nephrostomy vs. Fascial Stitch Following Percutaneous Nephrolithotripsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269108
Calculi, Female Urogenital Diseases
Cairo, Egypt
View Trial DetailsNCT05088213
Calculi, Female Urogenital Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT03855787
Calculi, Female Urogenital Diseases
Los Angeles, California, United States
View Trial DetailsNCT05701098
Calculi, Female Urogenital Diseases
San Diego, California, United States
View Trial Details